ArticleKidney medicine2026

Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗.

Elena Butz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.